07/02/2016 10:15:48 1-888-992-3836 (toll free) Free Membership Login

Xenoport News (NASDAQ:XNPT)

DateTimeSource
Headline
11/04/20154:05PMBWXenoPort Reports Third Quarter Financial Results
HORIZANT Net Product Sales Increase 94% Over Third Quarter 2014 XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2015. Net product sales for HORIZANT® (gabapentin enacarbil) Extended-Release Tablets nearly doubled to $11.0 million for the third quarter... More...>>
10/29/20152:19PMBWXenoPort to Present at the Credit Suisse Healthcare Conference
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2015 Credit Suisse Healthcare Conference in Phoenix, Arizona. The live presentation will occur at 9:30 a.m. Pacific Time (10:30 a.m. Mountain Time) on Wednesday, November 11, 2015. A replay of the... More...>>
10/27/201510:00AMBWXenoPort to Release Third Quarter Financial Results on November 4
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 4, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A... More...>>
10/01/20154:05PMBWXenoPort Announces Plan to Focus on its Growing HORIZANT Bus. & Names Vincent J. Angotti Chief Executive Officer & Director
XenoPort, Inc. (Nasdaq: XNPT) announced today a strategic shift to focus on and maximize the value of its commercial product, HORIZANT® (gabapentin enacarbil) Extended Release Tablets. As part of this shift, XenoPort will discontinue development of XP23829 on its own and seek to partner this and other high potential development... More...>>
09/15/20159:48AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to trade actively in Tuesday's session are Gray Television Inc. (GTN), XenoPort Inc. (XNPT) and Cheniere Energy Inc. (LNG). Gray Television continues to be an active acquirer, announcing a deal on Monday to buy Schurz Communications Inc.'s television and radio stations... More...>>
09/15/20156:30AMBWXenoPort Announces Positive Phase 2 Study Results for XP23829 as a Potential Treatment for Patients with Psoriasis
Efficacy observed with both 800 mg once-daily and 400 mg twice-daily XP23829 dosing XP23829 safe and generally well-tolerated with low incidence of flushing similar to placebo Low incidence/severity of lymphopenia seen with XP23829 First clinical demonstration of efficacy of a MMF prodrug other than DMF XenoPort, Inc... More...>>
09/04/201510:00AMBWXenoPort to Present at the Morgan Stanley Global Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Conference. The live presentation will occur at 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time) on Wednesday, September 16, 2015. A replay of the presentation will... More...>>
09/02/201510:30AMBWXenoPort to Present at the 2015 Wells Fargo Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2015 Wells Fargo Healthcare Conference. The live presentation will occur at 10:10 a.m. Pacific Time (1:10 p.m. Eastern Time) on Wednesday, September 9, 2015. A replay of the presentation will also... More...>>
08/05/20154:05PMBWXenoPort Reports Second Quarter Financial Results
HORIZANT Net Product Sales Increased 67% Over Second Quarter 2014 XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the second quarter and six months ended June 30, 2015. Total revenues for the second quarter were $8.6 million, compared to $5.3 million for the same period in 2014. Net loss for the second... More...>>
07/27/201510:00AMBWXenoPort to Release Second Quarter Financial Results on August 5, 2015
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its second quarter financial results on August 5, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A... More...>>
06/25/20158:30AMBWXenoPort Announces Initiation by NIAAA of Clinical Trial of HORIZANT in Patients with Alcohol Use Disorder
XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that the NIAAA has initiated a clinical trial of HORIZANT® (gabapentin enacarbil) Extended-Release Tablets as a potential treatment for alcohol use disorder (AUD). “This multi-site, well-controlled clinical... More...>>
06/08/20158:30AMBWHORIZANT (gabapentin enacarbil) Included in New Expert Recommendations on Prevention and Treatment of RLS Augmentation
XenoPort, Inc. (Nasdaq:XNPT) reported today that new expert recommendations for the prevention and treatment of augmentation in patients suffering from restless legs syndrome (RLS) list gabapentin enacarbil as a first-line therapy with a lower risk of developing augmentation. In addition, gabapentin enacarbil is listed... More...>>
06/02/20158:30AMBWXenoPort to Present New Pooled Data Analyses on HORIZANT (gabapentin enacarbil) at the 2015 SLEEP Annual Meeting
XenoPort, Inc. (Nasdaq: XNPT) announced today that pooled data analyses for HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, will be presented at the upcoming 29th Associated Professional Sleep Societies (APSS) annual SLEEP meeting in Seattle. The presentations include: Association Between Pain and Symptoms... More...>>
05/18/201510:00AMBWXenoPort to Present at the Jefferies 2015 Global Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Jefferies 2015 Global Healthcare Conference. The live presentation will occur at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) on Thursday, June 4, 2015. A replay of the presentation will also be... More...>>
05/07/20158:30AMBWXenoPort to Present New HORIZANT (gabapentin enacarbil) Data at the American Pain Society 34th Annual Scientific Meeting
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data for HORIZANT® (gabapentin enacarbil) Extended-Release Tablets at the American Pain Society 34th Annual Scientific Meeting in Palm Springs, CA. HORIZANT is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate-to-severe... More...>>
05/06/20154:05PMBWXenoPort Reports First Quarter Financial Results
XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2015. Revenues for the quarter were $7.1 million, compared to $3.4 million for the same period in 2014. Net loss for the first quarter was $20.4 million, compared to a net loss of $20.5 million for the same period... More...>>
05/01/20153:18PMARNZacks Lowers XenoPort to Hold (XNPT)
http://tickerreport.com/banking-finance/491451/zacks-lowers-xenoport-to-hold-xnpt/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/30/20152:29PMARNXenoPort Upgraded to "Buy" by Zacks (XNPT)
http://tickerreport.com/banking-finance/486917/xenoport-upgraded-to-buy-by-zacks-xnpt/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/28/20151:00PMBWXenoPort to Release First Quarter Financial Results on May 6, 2015
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 6, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A replay... More...>>
04/15/20158:30AMBWXenoPort to Present New Data Analyses for HORIZANT (gabapentin enacarbil) at the 67th Annual Meeting of the American Academy ...
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present pooled post-hoc analyses for gabapentin enacarbil, the active ingredient in HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, at the upcoming 67th Annual Meeting of the American Academy of Neurology in Washington, DC. HORIZANT is approved by the... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V:us D:20160207 15:15:50